Evaluation of Risk factors for the Prevalence of Kidney Failure(CKD & AKD) and The Impact of Clinical Pharmacists Role in Improving the Medication Adherence in Kidney Disease Patients of A Tertiary Care Teaching Hospital

  • R.Manogna Gayatri Department of Pharmacy Practice , Avanthi institute of Pharmaceutical Sciences Cherukupally,Bhogapuram.
  • M.Ujwala Department of Pharmacy Practice , Avanthi institute of Pharmaceutical Sciences Cherukupally,Bhogapuram.
  • A.S.Madhuri Department of Pharmacy Practice, Avanthi institute of Pharmaceutical Sciences Cherukupally,Bhogapuram.
    madhuri.alaghari@gmail.com
  • Uma Sankar Viriti Associate Professor,Department of Pharmacy Practice , Avanthi institute of Pharmaceutical Sciences Cherukupally,Bhogapuram.

Abstract

Aim : The aim of the study is to evaluate the risk factors for the prevalence of kidney failure (CKD & AKD ) and to analyse the role of clinical pharmacist in improving the medication adherence.Methodology : A prospective  interventional, analytical study was done on patients admitted in Maharaja Institute Of Medical Sciences Viziayanagaram ,AP, India . Information regarding the renal disease ,stages of CKD ,age ,gender ,causative factors ,serum creatinine ,dialysis, medication adherence ,reasons for non medication adherence ,were recorded in standerdquationnarie ( Case Report Form).


Results :Total 220 patients were included in this study , out of them 158(71.8%)patients were diagnosed with CKD &62 (28.1%) patients were diagnosed with AKD . Renal disease is high in male patients (63.1%) than in female patients (36.8%). Non medication adherence reasons and pharmacist counselling about medication adherence are the modifiable risk factore and got significant values in student T test (p value 0.0326 & 0.0478) using SPSS Software.


Conclusion: Hypertension Is The Major Riskfactor For Developing of Kidney Failure . More Patients Are Prone To Ckd When Compared To Akd .Kidney Failure Is Mostly Observed In Men Than In Women And They Are Mostly Diagnosed With Ckd Stage 5 .Lack Of Symptoms Is The Primary Factor For Non-Medication Adherence Among People. As There Is A Clear Evidence Seen Based On Data Obtained After Performing Patient Counselling And Patient Education ,We Conclude Clinical Pharmacists Could Play A Vital Role In Improving The Medication Adherence Among Ckd & Akd Patients Which Wil Ultimately Make The Patients Free From Ckd & Akd .

Keywords: Chronic Kidney Failur, Acute Kidney Failure, Case Report Form, Diagnosis

Downloads

Download data is not yet available.

References

1. Centers for Disease Control Prevention (CDC) (March 2007). "Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004". MMWR Morb. Mortal. Wkly. Rep. 56 (8): 161–65. PMID 17332726.
2. Morgan T (21 January 2009). "Chronic Kidney Disease (stages 3–5) prevalence estimates using data from the Neoerica study (2007)". Association of Public Health Observatories
3. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007). "Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury". Critical Care (London, England). 11 (2): R31. doi:10.1186/cc5713. PMC 2206446. PMID 17331245. Archived from the original on 2010-10-30.
4. Skorecki K, Green J, Brenner BM (2005). "Chronic renal failure". In Kasper DL, Braunwald E, Fauci AS, et al. Harrison's Principles of Internal Medicine(16th ed.). New York, NY: McGraw-Hill. pp. 1653–63. ISBN 0-07-139140-1.
5. Brady HR, Brenner BM (2005). "Chronic renal failure". In Kasper DL, Braunwald E, Fauci AS, et al. Harrison's Principles of Internal Medicine (16th ed.). New York, NY: McGraw-Hill. pp. 1644–53. ISBN 0-07-139140-1.
6. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004). "Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group". Crit Care. 8 (4): R204–^ Lameire N, Van Biesen W, Vanholder R (2005). "Acute renal failure". Lancet. 365 (9457): 417–30. doi:10.1016/S0140-6736(05)17831-3. PMID 15680458.
7. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (July 2008). "Intensity of renal support in critically ill patients with acute kidney injury". The New England Journal of Medicine. 359 (1): 7–20. doi:10.1056/NEJMoa0802639. PMC 2574780. PMID 18492867.
8. O'Connor, M. E.; Kirwan, C. J.; Pearse, R. M.; Prowle, J. R. (24 November 2015). "Incidence and associations of acute kidney injury after major abdominal surgery". Intensive Care Medicine. 42 (4): 521–30. doi:10.1007/s00134-015-4157-7. PMID 26602784.
9. Coca, SG; Singanamala, S; Parikh, CR (March 2012). "Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis". Kidney International. 81 (5): 442–48. doi:10.1038/ki.2011.379. PMC 3788581. PMID 22113526.
10. Schrier RW, Wang W, Poole B, Mitra A (2004). "Acute renal failure: definitions, diagnosis, pathogenesis, and therapy". J. Clin. Invest. 114 (1): 5–14. doi:10.1172/JCI22353. PMC 437979. PMID 15232604.
11. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (July 2006). "Chronic kidney disease and mortality risk: a systematic review". J. Am. Soc. Nephrol. 17 (7): 2034 47. doi:10.1681/ASN.2005101085. PMID 16738019.
12. Groothoff JW (July 2005). "Long-term outcomes of children with end-stage renal disease". Pediatr. Nephrol. 20 (7): 849–53. doi:10.1007/s00467-005-1878-9. PMID 15834618.
13. Wesseling C, Crowe J, Hogstedt C, Jakobsson K, Lucas R, Wegman DH (November 2013). "The epidemic of chronic kidney disease of unknown etiology in Mesoamerica: a call for interdisciplinary research and action". Am J Public Health. 103 (11): 1927–30. doi:10.2105/AJPH.2013.301594. PMC 3828726. PMID 24028232.
14. Johnson RJ, Sánchez-Lozada LG (October 2013). "Chronic kidney disease: Mesoamerican nephropathy – new clues to the cause". Nat Rev Nephrol. 9 (10): 560–61. doi:10.1038/nrneph.2013.174. PMID 23999393.
15. Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, Amaya JC, Calero DJ, Orellana P, Colindres RM, Velázquez ME, Núñez SG, Contreras VM, Castro BE (October 2011). "Chronic kidney disease and associated risk factors in the BajoLempa region of El Salvador: Nefrolempa study, 2009" (PDF). MEDICC Rev. 13 (4): 14–22. PMID 22143603.
16. KDIGO: Kidney Disease Improving Global Outcomes (August 2009). "KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)" (PDF). Kidney Int. 76 (Suppl 113).
17. Sandra L Kane - Gill et .al -“Drug Induced AKD: A focus on risk assessment for prevention”- Critical care clinics October 2015; 31 (4) . 675-684.
18. Paula F Orlandi, Naohikofuji et.al - “Haematuria as a risk factor for progression of CKD & death - j Bras Nefrol; 2014 Jan-Mar; 36(1) : 26-34.
19. Bebit baby et.al –“Evaluation of impact of Pharmaceutical care on Improving knowledge & medication adherence in CKD patients –INT J Pharm PharmSci ; published : 2016 Nov 23; vol 9, Issued 63-66.
20. Steven G coca et.al- AKD in Elderly Patients. Amj kidney Dis ; 2010 July ; 56(1) : 122-13.
Statistics
97 Views | 51 Downloads
Citatons
How to Cite
R, M. G., U. M, S. A, and U. S. Viriti. “Evaluation of Risk Factors for the Prevalence of Kidney Failure(CKD & AKD) and The Impact of Clinical Pharmacists Role in Improving the Medication Adherence in Kidney Disease Patients of A Tertiary Care Teaching Hospital”. World Journal of Current Medical and Pharmaceutical Research, Vol. 2, no. 2, May 2020, pp. 171-7, doi:10.37022/WJCMPR.2020.2216.
Section
Research Articles